Glycogen Storage Disease Type V Completed Phase 2 Trials for Valproic acid (DB00313)

Also known as: McArdle Disease / McArdles disease / Glycogenosis type V / McArdle's disease / Type V glycogen storage disease / GSD V

IndicationStatusPhase
DBCOND0002597 (Glycogen Storage Disease Type V)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03112889Sodium Valproate for GSDVTreatment